DCAT Board Of Directors Announcement

Paolo Magri, senior vice president, business development at Advitech SA, has been elected president for a second term of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Sean Diver, director, business development, early intermediates at Lonza, AG, as first vice president; Kerri McCullough Wood, senior vice president, head of TAPI commercial and Medis, TAPI, Teva Pharmaceuticals as second vice president; and Sally Macaluso, vice president and chief procurement officer for medical devices and business services, Johnson & Johnson as third vice president. All will serve one-year terms, ending October 31, 2020.

In addition, the following individuals have been newly elected or will continue to serve one-year terms on the board.

Directors

• Elodie Cramer, Associate Director, Global Procurement, Biogen
• Charles Davies, Associate Vice President, Global Sourcing & Procurement, Merck & Co. Inc.
• Gavin Murdoch, Senior Director, Strategic Partnerships, Pharma Services, Thermo Fisher Scientific
• Steve Poland, Director, 3rd Party FDF Sourcing, Mylan Inc.
• Lori Hoffman, Senior Director, Alliance Management, Frontida BioPharm, Inc.

Past Presidents

• Immediate Past President: Joe Sutton, Global Director, Sourcing, Eli Lilly and Company
• 2^nd Immediate Past President: Milton Boyer, CEO, SCA Pharmaceuticals

About DCAT
Founded in 1890, DCAT is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.